Account
Articles
09.06.2025
Early Advice, Long-Term Value: How HTA Engagement ...

The key to pricing success for any pharmaceutical product is effectively exhibiting the asset’...

Read more
Webinar
28.05.2025
Navigating Early Scientific Advice for Pricing and...

Whether you’re in drug development, market access, or health economics, early scientific advic...

Read more
06.03.2025
How to navigate early payer scientific advice: a B...

Charlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Insider Insights
29.09.2023
Switzerland's 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...

Read more
Case Studies
26.04.2023
Development and refinement of payer value messages

Conduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...

Read more
Case Studies
26.04.2023
Our client wanted to gain an understanding

Our client wanted to gain an understanding of payer willingness to pay and determine the likely clin...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client wanted to understand the clinical and economic evidence requirements that drive payer dec...

Read more
Articles
03.04.2023
What is the joint clinical assessment and what doe...

We explore what the joint clinical assessment (JCA) is, its process and what future developments may...

Read more
Case Studies
27.01.2023
Payer value proposition development

Payer value proposition development and understanding evidence requirements to secure pricing and re...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.